Adherence to anti-seizure medications among persons living with epilepsy attending a community- based epilepsy clinic in Buikwe and Mukono Districts-Uganda: A mixed methods study
Ronald Kibirige, Marianna Agaba Nyangire, Mark Kaddumukasa, Christine Muhumuza, Christopher Burant, Shirley Moore, Elly T Katabira, Martha Sajatovic · 2026
Read Adherence to anti-seizure medications among persons living with epilepsy attending a community- based epilepsy clinic in Buikwe and Mukono Districts-Uganda: A mixed methods study by Ronald Kibirige, Marianna Agaba Nyangire, Mark Kaddumukasa, Christine Muhumuza, Christopher Burant, Shirley Moore, Elly T Katabira, Martha Sajatovic (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0356494.txt.
Description
Ronald Kibirige and colleagues studied epilepsy care in two districts of central Uganda, Buikwe and Mukono, in 2026 work based on fieldwork from 2024. People with epilepsy there attend community clinics and depend on daily anti-seizure medicine to stay safe. The team set out to learn how many patients actually take their medicine as directed, and what helps or gets in the way.
About two thirds of the nearly three hundred patients surveyed were taking their medicine well. Better adherence was linked with a modest steady income, while long waits at the clinic and too-low doses were linked with worse adherence. Interviews added human detail: fear of stigma, money worries, family support, and mistaken beliefs about the drugs all shaped whether patients kept up their treatment.
Catalog record
| CREATOR | Ronald Kibirige, Marianna Agaba Nyangire, Mark Kaddumukasa, Christine Muhumuza, Christopher Burant, Shirley Moore, Elly T Katabira, Martha Sajatovic |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52434 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |